Product Images Mitomycin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Mitomycin NDC 65219-568 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
mitomycin-spl-structure - mit08 0000 01
Fresenius Kabi Logo - mit08 0000 02
Principal Display Panel – Mitomycin for Injection, USP 40 mg/vial – Carton - mit08 0000 03
Mitomycin for Injection is a cytotoxic agent that is administered intravenously to avoid tissue damage. It comes in a single-dose vial that contains 40 mg of Mitomycin and 80 mg of Mannitol. Sterile water for injection must be added to the vial to create the solution. The reconstituted solution must be stored in the refrigerator between 2°C to 8°C and should be discarded after 14 days. The dosage is indicated in the package insert, which contains full prescribing information.*
Principal Display Panel – Mitomycin for Injection, USP 40 mg/vial – Vial Label - mit08 0000 04
This is a prescription-only vial containing 40mg of mitomycin and 80mg of mannitol. It should be diluted with 80mL of sterile water for injection, USP and shaken to dissolve. Each mL of reconstituted solution will contain 0.5mg of mitomycin and have a pH between 6.0 and 8.0. This is a cytotoxic agent that must be administered intravenously to avoid tissue damage. It should be stored in the carton between 15°C and 30°C and protected from light. The dry powder should be stored between 2°C and 8°C, while the reconstituted solution should be stored under refrigeration and discarded after 14 days.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
